Document Detail

Mobile telemonitoring for achieving tighter targets of blood pressure control in patients with complicated diabetes: a pilot study.
MedLine Citation:
PMID:  20597833     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Hypertension is a major risk factor for the long-term complications of diabetes. Mobile, self-measurement of blood pressure is emerging as a method to manage blood pressure in general, but its impact in patients with diabetes is unclear. METHODS: We randomized 137 patients with diabetes and hypertension to either mobile telemonitoring (n = 72) or usual care (n = 65). Clinic blood pressure was recorded at baseline and after 6 months. Patients in the intervention arm transmitted weekly blood pressure readings wirelessly, using adapted sensors via mobile phones to a central server. Clinicians received the data in real-time and using a web-based application provided management advice to the patient and their physicians. RESULTS: Systolic blood pressure fell significantly in the patients in the intervention group (mean [95% confidence interval], -6.5 [-0.8 to -12.2] mm Hg; P = 0.027) and remained unchanged in the control group (2.1 [9.3 to -5.0] mm Hg; P = 0.57). Patients within the intervention arm of African origin seemed to benefit more from the intervention. In addition, those who achieved a systolic blood pressure of <120 mm Hg had lower average blood sugars than those with higher readings (7.8 [SD 1.6] vs. 8.9 [SD 2.2] mmol/L; P = 0.02). CONCLUSIONS: In patients with diabetes, mobile telemonitoring has potential for delivering intensified care to improve blood pressure control, and its use may be associated with reduced exposure to hyperglycemia.
Kenneth A Earle; Robert S H Istepanian; Karima Zitouni; Ala Sungoor; Bee Tang
Related Documents :
1013693 - The problems of morbidity and therapy in borderline hypertension.
20597833 - Mobile telemonitoring for achieving tighter targets of blood pressure control in patien...
21894443 - Testosterone-dependent increase in blood pressure is mediated by elevated cyp4a express...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Diabetes technology & therapeutics     Volume:  12     ISSN:  1557-8593     ISO Abbreviation:  Diabetes Technol. Ther.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-05     Completed Date:  2010-11-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100889084     Medline TA:  Diabetes Technol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  575-9     Citation Subset:  IM    
Thomas Addison Unit, St. George's Hospital NHS Trust, London, United Kingdom.
Data Bank Information
Bank Name/Acc. No.:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Glucose / analysis*
Blood Pressure / physiology*
Diabetes Complications / complications,  metabolism,  therapy*
Great Britain
Hypertension / complications,  physiopathology,  therapy*
Middle Aged
Pilot Projects
Statistics, Nonparametric
Telecommunications / standards*
Urban Population
Reg. No./Substance:
0/Blood Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The impact of baseline hemoglobin a1c levels prior to initiation of pump therapy on long-term metabo...
Next Document:  Skin autofluorescence and glycemic variability.